with a defect in protein metabolism, may on occasion produce other bizarre and even misleading changes in the plasma constituents.
Isolated reports of unusual cases, such as those of Cantarow in 1935 and Nassim and Crawford in 1950, have appeared from time to time in the literature ; but more comprehensive reviews show such a divergence of opinion on the frequency with which these abnormal " ancillary " biochemical findings occur that it seemed of practical value to give in condensed form the analysis on 74 proved cases of myelomatosis examined and followed in this department in the course of a much wider study of the causes and significance of hyperglobulinaemia.
The histograms refer to the levels found in the first samples submitted to the laboratory from each patient. To have grouped all the analyses carried out would, we believe, have given an artificial picture, for it is natural that unusual values have been repeated more often than normal values; moreover, " terminal " values, except in the rare instances when patients were admitted undiagnosed in extremis, are not of great practical value. Of greater interest are the bizarre findings encountered when the patient first comes to the doctor.
Methods
Total Protein.-This was estimated as total nitrogen by the micro-Kjeldahl distillation techrlique of Pregl, and, after subtraction of the non-protein nitrogen, converted to protein using a factor of 6.25.
Urea.-Urea was estimated by a modification (Harrison, 1947) of the urease-Nesslerization method of Archer and Robb (1925) .
Uric Acid. The estimation was carried out by the method of Brown (1945) , which gives values not more than 0.2 mg. above the true uric acid levels except in renal damage.
Cholesterol.-Cholesterol was estimated using the Liebermann-Burchardt reaction by a modification of the methods of Bloor (1928) or Sackett (1925) . The estimation was carried out on 1 ml. of serum.
Alkaline Phosphatase.-This was estimated by determining the liberated phenol from diphenyl phosphate with Folin and Ciocalteau's phenol reagent, using the micro-method of King and Armstrong (King, 1956 above the normally accepted upper limits of 47 mg. for 100 ml. Of the patients with a blood urea over 100, two were admitted with advanced renal failure, the diagnosis of myelomatosis being unsuspected at the time of admission.
Calcium Levels.-Twenty-two per cent. were above the limits of normal, and 10% below normal limits (Fig. 3 recorded below 2 mg./100 ml.; 33% had P levels above 4 mg./100 ml. Of these, one, with a level of 12.7 mg./100 ml., was in advanced renal failure. (Fig. 5) .
Maximal individual fluctuations from follow-up data on five patients are shown in Table III There was no precise relation between the extent of bone involvement as judged radiologically and the phosphatase levels. Fig. 6 shows initial plasma uric acid levels of 18 patients; eight were above the upper normal limit, and, though the highest levels observed were in a patient with a considerable degree of associated renal damage (see Table II ), uric acid levels were above normal in four patients in which there is no clear evidence of renal damage, and of the 18 analyses only two were below the mean of the normal span.
Cholesterol Levels.-These were analysed in 20 patients. Two were above the upper normal limit of 250 mg./100 ml. One of these was a diabetic of six years' standing.
Discussion
It might be expected that the widespread use of electrophoretic technique, and the bizarre protein pattern it discloses in more than 80% of patients with myelomatosis, would help to establish the diagnosis with greater confidence at an earlier stage in the course of disease. We are not convinced, from a plot of the age incidence of the present series (Fig. 7) , that it has materially altered the age at which the diagnosis is established. Lawrence (1949) found 24 out of 45 cases had calcium levels above 12 mg. /100 ml., while Snapper, Turner, and Moscovitz (1953) report 30 out of 80 cases studied with a serum calcium level above 12 mg. /100 ml. In the present series, 13 out of 70 patients had blood calcium levels above 12 mg./100 ml. when first examined. The highest calcium level we have found was 17.0 mg. /100 ml., though much higher levels are recorded in the literature, up to 18.8 mg./ 100 ml. by Robbins and Kydd (1935) and 20 mg./ 100 ml. by Schittenhelm (1929) . Cantarow, in 1935, described a patient whose blood calcium fluctuated between 12.9 mg. and 9.2 mg./100 ml. We have only seen one instance of a fluctuation as great as this in a patient suffering from progressive renal failure, though lesser fluctuations are common.
Unlike patients with active parathyroid adenoma, the serum inorganic phosphorus levels were never below 2 mg./100 ml. Indeed, only four out of 51 initial analyses were below 2.5 mg./ 100 ml. and at no stage in the condition have we recorded a value below 2.2 mg./100 ml.
At initial examination when less than 15% of the present series had blood urea levels suggestive of some renal damage, 33% had levels of serum inorganic phosphorus above 4 mg./100 ml., suggesting that the raised phosphorus levels often seen in myelomatosis are not the result of renal damage alone.
It is tempting to imagine that they are related to the increased turnover of nucleoprotein and to couple the observation with the relatively high plasma uric acids commonly recorded. Table II shows that three patients of the present series had uric acid levels of 5.4, 6.6, and 7 mg. /100 ml. respectively at a time when urea clearance studies suggested an adequate renal function. The levels of uric acid do not show any relation to levels of circulating proteins.
There is little agreement in the literature on the levels of alkaline phosphatase. Bayrd and Heck (1947) 
